Next, we sought to investigate whether PKM2 deficiency mitigates LPS-induced inflammation and apoptosis since these pathways have been identified to play a key role in mediating the pathogenesis of AKI during its early phases. The gene discussed is PKM; the disease is acute kidney injury.